Yayın:
DIO2Thr92Ala Reduces Deiodinase 2 Activity and Serum T3 Levels in Patients with Schizophrenia

Basit öğe sayfası
dc.contributor.authorOzgen, O.
dc.contributor.authorAkan, G.
dc.contributor.authorColak, A.
dc.contributor.authorAcar, S.
dc.contributor.authorOncu, F.
dc.contributor.authorYanbay, H.
dc.contributor.authorYesilbursa, D.
dc.contributor.authorTurkcan, S.
dc.contributor.authorAtalar, F.
dc.date.accessioned2026-06-27T14:34:41Z
dc.date.issued2020
dc.identifier.eissn1476-5438
dc.identifier.endpage893
dc.identifier.issn1018-4813
dc.identifier.issueSUPPL 1
dc.identifier.startpage892
dc.identifier.urihttps://hdl.handle.net/20.500.14981/62291
dc.identifier.volume28
dc.identifier.wos000598482603197
dc.language.isoeng
dc.publisherSPRINGERNATURE
dc.relation.ispartofEUROPEAN JOURNAL OF HUMAN GENETICS
dc.subjectBiochemistry & Molecular Biology
dc.subjectGenetics & Heredity
dc.titleDIO2Thr92Ala Reduces Deiodinase 2 Activity and Serum T3 Levels in Patients with Schizophrenia
dc.typeMeeting Abstract
dspace.entity.typePublication
local.import.sourceWOS

Dosyalar

Koleksiyonlar

Yayınlar